{"disease":{"id":"hormone-sensitive-breast-cancer","name":"hormone sensitive breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01446159","title":"Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"MedImmune LLC","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}